NCT02637102

Brief Summary

CAVIAR is a multicentre prospective observational study. Centres for cardiac and vascular surgery assess and manage patients in different ways before surgery. Some centres have introduced the use of intravenous iron therapy for patients with anaemia in the preoperative setting. Consequently regional variation exists in the assessment and management of patients before cardiac and vascular surgery. We aim to observe and measure these differing pathways and observe if there is variation in iron deficiency and anaemia and the impact of these variables on patient cardiorespiratory function as well as post-operative outcomes. \[Sub-Study\] For patients who are receiving intravenous iron therapy as part of their routine clinical care, we wish to observe this effect in more detail. We will assess the impact of the treatment on well-being, blood count and fitness. Information will be collected through Quality of Life questionnaires, total haemoglobin mass test (via blood collection) and fitness testing.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
425

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2015

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2015

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

November 27, 2015

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 22, 2015

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

2.3 years

First QC Date

November 27, 2015

Last Update Submit

May 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Haemoglobin

    From baseline to before surgery (within 10-42 days)

Secondary Outcomes (11)

  • Changes in biomarkers of iron deficiency (e.g. hepcidin, ferritin, TfSats)

    From baseline to after IV iron (within 4-6 weeks before surgery)

  • Haemoglobin

    Before surgery (within 10-42 days) to post surgery (within 3 weeks)

  • Unit of blood transfused

    Hospital stay (within 7 days)

  • ICU and hospital length of stay

    Within 30 days

  • Renal function (change in creatinine)

    From baseline to before surgery (within 10-42 days)

  • +6 more secondary outcomes

Study Arms (1)

Patients undergoing cardiac or vascular surgery

Other: Not applicable - observational study

Interventions

Patients undergoing cardiac or vascular surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients requiring major cardiac or vascular surgery will be identified from routine clinical care. Most patients are routinely referred for pre-operative assessment, although local protocols vary between centres. Assesments at the pre-operative assessment clinic (PAC) may include (but not limited to) routine blood tests (full blood count, urea and electrolytes, etc.), history and examination, cardiorespiratory fitness assessment by 6 minute walk test (6MWT) or cardiopulmonary exercise testing (CPET). In some centres, patients with anaemia will receive intravenous iron at PAC or in a separate anaemia clinic.

You may qualify if:

  • Male and female adults aged 18 years or older
  • Screening \[Hb\] \< 120 g/L (for females) or \< 130g/L (for males)
  • Undergoing elective cardiac OR vascular surgery:
  • Coronary artery bypass (CABG), or valvular surgery, or combined CABG and valve surgery.
  • Repair or replacement of thoracic or abdominal aorta (open or endovascular).
  • Able to provide informed consent
  • (if applicable) Able to perform CPET or 6MWT if consented to take part in the sub study

You may not qualify if:

  • Pregnancy or lactation
  • Adults with known underlying history of learning disabilities, or adults who do not have mental capacity to consent for themselves
  • Prisoners
  • Renal dialysis (current or planned within the next 12 months)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Chau M, Richards T, Evans C, Butcher A, Collier T, Klein A. The UK Cardiac and Vascular Surgery Interventional Anaemia Response (CAVIAR) Study: protocol for an observational cohort study to determine the impact and effect of preoperative anaemia management in cardiac and vascular surgical patients. BMJ Open. 2017 Apr 18;7(4):e014872. doi: 10.1136/bmjopen-2016-014872.

Related Links

MeSH Terms

Conditions

Iron DeficienciesAnemia

Condition Hierarchy (Ancestors)

Iron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

  • Toby Richards, MD FRCS

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2015

First Posted

December 22, 2015

Study Start

November 1, 2015

Primary Completion

March 1, 2018

Study Completion

April 1, 2019

Last Updated

May 16, 2023

Record last verified: 2023-05